← Back to archive

Isomorphic Labs is launching human trials of AI-designed drugs

Alphabet’s Isomorphic Labs wants to solve diseases with AI. They’re about to launch their first human trials of AI-designed drugs.

Isomorphic raised $600M in April 2025 and is pairing AlphaFold’s breakthrough tech with pharma experts to create new medicines faster and more accurately. They're already designing cancer drugs with AI in their London office. Faster drug development, lower costs, and way higher chances of success.

  • AlphaFold’s original protein predictions were just the beginning. Now it models interactions with DNA and drugs.
  • Isomorphic isn’t just supporting big pharma - they’re also creating their own drug candidates.

Their ultimate vision - identify a disease and "prints out" a custom drug to treat it. 🤯

Isomorphic Labs is launching human trials of AI-designed drugs

Originally posted on X

PS: I'm pretty active on 𝕏 if you'd like to follow along

Archive

2026

2025

2024

2018